Clinical Trial Update: Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating induction chemotherapy combined with camrelizumab for locoregionally advanced hypopharyngeal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hypopharyngeal Cancer, Immunotherapy | Phase 2 | Status: UNKNOWN